394 related articles for article (PubMed ID: 16123358)
21. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
[TBL] [Abstract][Full Text] [Related]
22. A form of mitofusin 2 (Mfn2) lacking the transmembrane domains and the COOH-terminal end stimulates metabolism in muscle and liver cells.
Segalés J; Paz JC; Hernández-Alvarez MI; Sala D; Muñoz JP; Noguera E; Pich S; Palacín M; Enríquez JA; Zorzano A
Am J Physiol Endocrinol Metab; 2013 Nov; 305(10):E1208-21. PubMed ID: 23941871
[TBL] [Abstract][Full Text] [Related]
23. Novel mitofusin 2 splice-site mutation causes Charcot-Marie-Tooth disease type 2 with prominent sensory dysfunction.
Martikainen MH; Kytövuori L; Majamaa K
Neuromuscul Disord; 2014 Apr; 24(4):360-4. PubMed ID: 24530046
[TBL] [Abstract][Full Text] [Related]
24. Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha.
Sewter C; Berger D; Considine RV; Medina G; Rochford J; Ciaraldi T; Henry R; Dohm L; Flier JS; O'Rahilly S; Vidal-Puig AJ
Diabetes; 2002 Apr; 51(4):1035-41. PubMed ID: 11916923
[TBL] [Abstract][Full Text] [Related]
25. Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion.
Vielhaber S; Debska-Vielhaber G; Peeva V; Schoeler S; Kudin AP; Minin I; Schreiber S; Dengler R; Kollewe K; Zuschratter W; Kornblum C; Zsurka G; Kunz WS
Acta Neuropathol; 2013 Feb; 125(2):245-56. PubMed ID: 22926664
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
Kijima K; Numakura C; Izumino H; Umetsu K; Nezu A; Shiiki T; Ogawa M; Ishizaki Y; Kitamura T; Shozawa Y; Hayasaka K
Hum Genet; 2005 Jan; 116(1-2):23-7. PubMed ID: 15549395
[TBL] [Abstract][Full Text] [Related]
27. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease].
Sołtysińska E; Kabzińska D; Kochański A
Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344
[TBL] [Abstract][Full Text] [Related]
28. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in Type II diabetic subjects.
Schrauwen P; Schaart G; Saris WH; Slieker LJ; Glatz JF; Vidal H; Blaak EE
Diabetologia; 2000 Nov; 43(11):1408-16. PubMed ID: 11126411
[TBL] [Abstract][Full Text] [Related]
29. Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients.
Hernández-Alvarez MI; Chiellini C; Manco M; Naon D; Liesa M; Palacín M; Mingrone G; Zorzano A
Diabetologia; 2009 Aug; 52(8):1618-27. PubMed ID: 19504086
[TBL] [Abstract][Full Text] [Related]
30. Intact initiation of autophagy and mitochondrial fission by acute exercise in skeletal muscle of patients with Type 2 diabetes.
Kruse R; Pedersen AJ; Kristensen JM; Petersson SJ; Wojtaszewski JF; Højlund K
Clin Sci (Lond); 2017 Jan; 131(1):37-47. PubMed ID: 27837193
[TBL] [Abstract][Full Text] [Related]
31. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
32. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
[TBL] [Abstract][Full Text] [Related]
33. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
34. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons.
Rizzo F; Ronchi D; Salani S; Nizzardo M; Fortunato F; Bordoni A; Stuppia G; Del Bo R; Piga D; Fato R; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2016 Oct; 25(19):4266-4281. PubMed ID: 27506976
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans.
Binnert C; Koistinen HA; Martin G; Andreelli F; Ebeling P; Koivisto VA; Laville M; Auwerx J; Vidal H
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1072-9. PubMed ID: 11052962
[TBL] [Abstract][Full Text] [Related]
36. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
Cartoni R; Martinou JC
Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
[TBL] [Abstract][Full Text] [Related]
37. Ferritin levels and hepcidin mRNA expression in peripheral mononuclear cells from anemic type 2 diabetic patients.
Andrews M; Arredondo M
Biol Trace Elem Res; 2012 Oct; 149(1):1-4. PubMed ID: 22426798
[TBL] [Abstract][Full Text] [Related]
38. MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue.
Capel E; Vatier C; Cervera P; Stojkovic T; Disse E; Cottereau AS; Auclair M; Verpont MC; Mosbah H; Gourdy P; Barraud S; Miquel A; Züchner S; Bonnefond A; Froguel P; Christin-Maitre S; Delemer B; Fève B; Laville M; Robert J; Tenenbaum F; Lascols O; Vigouroux C; Jéru I
J Clin Lipidol; 2018; 12(6):1420-1435. PubMed ID: 30158064
[TBL] [Abstract][Full Text] [Related]
39. Developmental defects and neuromuscular alterations due to mitofusin 2 gene (MFN2) silencing in zebrafish: a new model for Charcot-Marie-Tooth type 2A neuropathy.
Vettori A; Bergamin G; Moro E; Vazza G; Polo G; Tiso N; Argenton F; Mostacciuolo ML
Neuromuscul Disord; 2011 Jan; 21(1):58-67. PubMed ID: 20951042
[TBL] [Abstract][Full Text] [Related]
40. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
Kim YB; Kotani K; Ciaraldi TP; Henry RR; Kahn BB
Diabetes; 2003 Aug; 52(8):1935-42. PubMed ID: 12882908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
